MRNA Stock Up 3%, Moderna Resubmits Application for Vaccine Booster Shots for All Adults
The anticipation of a booster shot approval has sent Moderna shares up.
SafePal Introduces Innovative Airdrop Mechanism Wallet Holder Offering (WHO)
SafePal’s WHO mechanism is a unique and secure way of rewarding users via airdrops. The platform aims to simplify some redundant and costly tasks thereby allow blockchain project teams to focus on development.
AZN Stock Jumped 3%, WHO Approves AstraZeneca Coronavirus Vaccine for Emergency Use
Notably, the World Health Organization has approved two different versions of the AstraZeneca vaccine that were found out to be approximately 63% effective.
Vaccine Rollout Influences Investment Decisions as Pfizer and BioNTech Agree to Supply COVAX Program Co-led by WHO
Pfizer and BioNTech will supply a COVAX program to accelerate vaccine distribution in lower-income countries.
Moderna Releases Q3 Earnings as It Confirms Its Geared Up Activity to Meet Up with Its Vaccine Demand
Massachusetts-Based biotechnology company Moderna Inc (NASDAQ: MRNA), one of the top pharmaceutical companies in search of a COVID-19 vaccine, has released its Q3 financial earnings while confirming its preparations to meet up with the expected surge in demand for its vaccine once approved.
WHO Study Shows Remdesivir Is Not as Potent in Reducing COVID-19 Mortality Rate as Claimed
The increasing rise in COVID-19 cases may further stir a boost in the demand for Remdesivir despite the WHO claims.
Gold Price Peaks Above $1800 for the First Time Since 2011
Gold is currently experiencing a new price high since 2011. This increase is fueled on grounds of possible measures to help curtail the new rising cases COVID-19.
AZN Stock Up 0.6%, WHO Marks AstraZeneca and Moderna as Leaders in Race for COVID-19 Vaccine
The World Health Organization highlighted the progress of AstraZeneca seeking for the COVID-19 vaccine. UK-based company has moved to the human trial stage. Moderna is not far behind.
U.S. Stock Futures Open Flat, Asian Indices Drag Down as COVID-19 Deaths Cross Half-A-Million
The global markets remain jittery as the total COVID-19 death count crosses the half-a-million mark. The WHO has warned of the latest acceleration in global access and called for new measures to combat this pandemic through public-private partnerships.
CureVac Set to Begin Human Trials of Coronavirus Vaccine in Germany
CureVac is joining the row of biotech companies that are ready to test their coronavirus vaccine candidates on patients.
AZN Stock Down 2% Yesterday, AztraZeneca to Provide 2 Billion COVID-19 Vaccine Doses
AstraZeneca plans to deliver 1 billion doses of a COVID-19 vaccine to developing countries, 400 million doses can become available this year. Moreover, 400 million doses will be sent to the U.S. and the United Kingdom. AZN stock is up in the pre-market.
Bill Gates-backed Vaccine Alliance GAVI Set for $7.4 Billion Fundraising
The funds that Bill Gates-backed GAVI is going to raise are meant to assist failing healthcare systems in the world’s poorest countries.
GILD Stock Down 3.5% Yesterday, Up 0.5% Now, Gilead to Supply Remdesivir to 127 Countries
By Darya Rudz
As Gilead Sciences has said, the 127 countries on the remdesivir distribution list vary from low- to high-income countries. All of them face barriers in getting healthcare access. Meanwhile, now GILD stock is up after falling 3.53% yesterday.
Inovio (INO) Pharmaceuticals Stock Fell 5% as Class Action Lawsuit Brews
By Tolu Ajiboye
Inovio Pharmaceuticals might see a plunge in its 2020 gains if a class action lawsuit proves the company deliberately misled the public. Yesterday, INO stock lost over 5% of its value.
Fujifilm to Send Its Coronavirus Drug Favipiravir to Over 40 Countries for Trials
Fujifilm (FUJIY) shares closed with a 0.95% rise yesterday after the company confirmed it will send its favipiravir coronavirus drug to over 40 countries for trials.